Belgium· BE-AMP-SAM335273-00
Otrivine Duo 0.5 mg/ml - 0.6 mg/ml
A xylometazoline product containing ipratropium bromide, registered in Belgium by Haleon Belgium. The same ATC class is registered in 10 of our 19 countries.
Checked against FAMHP / AFMPS (Belgium) on
Informational only — not a medical device.
Where it is registered
Xylometazoline is registered in 10 of 19 countries.
Countries holding a registration under ATC R01AB06 (xylometazoline), each read from that country’s own register.
- This record: Belgium, from FAMHP / AFMPS (Belgium)
- 7 of them publish a price we can compare per daily dose
Xylometazoline · ATC R01AB06
10 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
The record
At a glance
FAMHP / AFMPS (Belgium)- Active substance
- Ipratropium Bromide
- Manufacturer
- Haleon Belgium
- Country
- Belgium (BE)
- ATC code
- R01AB06
- ATC class
- Xylometazoline
- Reimbursed
- Not published by this register
- Source register
- FAMHP / AFMPS (Belgium)
- Last checked
- September 26, 2026
Packs & prices · 1
- be_apb4902045
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
63 interactions on record for xylometazoline.
Graded by severity as the source publishes them — 6 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Xylometazoline · interactions on record
63 records
- 6 severe
- 54 moderate
Most severe, free to view
- MethylergometrineG02AB01severe
- DihydroergotamineN02CA01severe
- ErgotamineN02CA02severe
- MethysergideN02CA04severe
3 more interactions with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Xylometazoline in 16 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United KingdomAtrovent 20micrograms/dose AutohalerBoehringer Ingelheim Ltd
- United StatesAtroventBoehringer Ingelheim Pharmaceuticals, Inc.
- FinlandAtroventParanova Oy
- SwedenAtrovent 0,25 mg/ml Lösning för nebulisatorBoehringer Ingelheim International GmbH
- FranceATROVENT 20 microgrammes/dose, solution pour inhalation en flacon pressuriséBOEHRINGER INGELHEIM FRANCE
- GermanyAtroventBoehringer Ingelheim Pharma Gmbh & Co. Kg
- NetherlandsAtrovent 20 microgram/dosis, aërosol, oplossingBoehringer Ingelheim B.V.
- CanadaAA-IPRAVENTAA PHARMA INC
Authorised across Europe · EMA
The same active substance is authorised in 26 EEA countries. Names it is sold under:
- Austria · Atrovent - Dosieraerosol, Ipratropiumbromid Infectopharm
- Cyprus · Atrovent
- Czechia · Atrovent, Atrovent N
- Germany · Atrovent, Atrovent Ls
- Denmark · Atrovent, Ipratropiumbromid Teva
- Estonia · Atrovent N
- Spain · Atroaldo, Atrovent
- Finland · Atrovent, Atrovent Eco
- France · Atrovent, Atrovent Adultes
- United Kingdom (Northern Ireland) · Atrovent Inhaler Cfc-Free, Atrovent Udvs
- Greece · Atrovent, Broncovent
- Croatia · Atrovent, Atrovent N
- Hungary · Atrovent N
- Ireland · Atrovent 250 Udvs, Atrovent 500 Udvs
- Iceland · Atrovent, Lomuspray
- Italy · Atem, Nasipral
- Lithuania · Atrovent N
- Luxembourg · Atrovent, Atrovent Hfa
- Malta · Atroaldo, Atrovent Inhaler Cfc-Free
- Netherlands · Atrovent, Atrovent Unit Dose
- Norway · Atrovent, Ipraxa
- Poland · Atrodil, Atrovent
- Portugal · Atrovent, Atrovent Pa
- Romania · Ipravent Inhaler
- Sweden · Atrovent, Ipravent
- Slovakia · Atrovent N
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/fa3f19d4-3c9f-4637-8818-3016115a5d26 GET /v1/drugs/fa3f19d4-3c9f-4637-8818-3016115a5d26?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Nasal spray, solution",
"source": "afmps",
"status": "AUTHORIZED",
"name_en": "Otrivine Duo 0.5 mg/ml - 0.6 mg/ml",
"name_fr": "Otrivine Duo 0.5 mg/ml - 0.6 mg/ml",
"name_nl": "Otrivine Duo 0.5 mg/ml - 0.6 mg/ml",
"amp_code": "SAM335273-00",
"strengths": [
"0.6000",
"0.6000",
"0.5000",
"0.5000",
"0.5000",
"27.9000"
],
"pack_count": 1,
"substances": [
"Ipratropium Bromide",
"Xylometazoline Hydrochloride",
"Disodium Edetate",
"Glycerol",
"Sodium Hydroxide"
],
"medicine_type": "ALLOPATHIC",
"atc_description": "Xylometazoline",
"authorisation_numbers": [
"BE335273"
]
}See everything about xylometazoline.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.